Eonomists from the University of Mexico have calculated the losses of the pharmaceutical companies on the legalization of the Cannes plan sed. This phenomenon took on a massive character, and the medical business became worried, even there were cases of lobbying by pharmaceutical companies for the non-distribution of marijuana. The reason is simple – they got access to “weed”, people stopped buying antidepressants and navi drugs.
A period capture study over the past 25 years, for a single linkage of cannabis market data, which has fallen by 2% minimum every p, code in a rotating state or city, has met the legalization of cannab materials. This has resulted in up to $3 billion in lost drug sales per year for each such event.
Currently, cannabis is not yet legalized in 16 states, and if this happens, the big pharmaceutical business will lose another 11% of profits, which is about $38 billion. restrictions for use. Worst of all is the number of manufacturers of branded drugs, their share is projected at 229% rest.
Source: Tech Cult
